Kensington Investment Counsel’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
7,098
-29
| -0.4% | -$7.48K | 0.79% | 41 |
|
|
2025
Q1 | $1.6M | Sell |
7,127
-137
| -2% | -$30.7K | 0.71% | 47 |
|
|
2024
Q4 | $1.66M | Sell |
7,264
-33
| -0.5% | -$7.55K | 0.69% | 48 |
|
|
2024
Q3 | $1.78M | Buy |
7,297
+25
| +0.3% | +$6.1K | 0.74% | 47 |
|
|
2024
Q2 | $1.39M | Sell |
7,272
-2,798
| -28% | -$536K | 0.62% | 50 |
|
|
2024
Q1 | $1.99M | Buy |
10,070
+704
| +8% | +$139K | 0.91% | 41 |
|
|
2023
Q4 | $1.61M | Buy |
9,366
+133
| +1% | +$22.9K | 0.84% | 40 |
|
|
2023
Q3 | $1.37M | Buy |
9,233
+3,784
| +69% | +$560K | 0.85% | 43 |
|
|
2023
Q2 | $1.19M | Sell |
5,449
-82
| -1% | -$17.9K | 0.75% | 47 |
|
|
2023
Q1 | $1.21M | Sell |
5,531
-548
| -9% | -$120K | 0.91% | 46 |
|
|
2022
Q4 | $1.27M | Hold |
6,079
| – | – | 0.99% | 45 |
|
|
2022
Q3 | $1.33M | Buy |
6,079
+34
| +0.6% | +$7.42K | 1.12% | 43 |
|
|
2022
Q2 | $1.27M | Sell |
6,045
-142
| -2% | -$29.8K | 1.08% | 41 |
|
|
2022
Q1 | $1.5M | Sell |
6,187
-682
| -10% | -$165K | 0.99% | 48 |
|
|
2021
Q4 | $1.79M | Buy |
+6,869
| New | +$1.79M | 1.04% | 45 |
|
|
2021
Q2 | $1.47M | Buy |
5,945
+141
| +2% | +$34.8K | 1.01% | 49 |
|
|
2021
Q1 | $1.13M | Buy |
5,804
+380
| +7% | +$73.7K | 0.85% | 58 |
|
|
2020
Q4 | $1.15M | Buy |
+5,424
| New | +$1.15M | 0.95% | 55 |
|